$200.00
Melanotan 2 is a synthetic melanocortin receptor agonist studied for its interaction with MC1R and related melanocortin receptor pathways. In controlled research environments, MT-2 is evaluated for its influence on pigmentation signaling, melanogenesis pathways, and central melanocortin activity.
As a cyclic peptide analog of alpha-MSH (melanocyte-stimulating hormone), Melanotan 2 is examined in laboratory models exploring skin pigmentation dynamics and neuroendocrine signaling frameworks.
Research Name: Melanotan 2
Alias: MT-2
Category: Melanocortin receptor agonist
Primary Research Focus: Melanogenesis modeling, melanocortin pathway activation, pigmentation signaling
Format: Lyophilized powder
Upon reconstitution with an appropriate volume of bacteriostatic water, final concentration will vary depending on total diluent added. Researchers calculate concentration using the standard formula:
Total mg in vial ÷ Total mL added = mg per mL
For U-100 insulin syringes:
1 mL = 100 units
Units required are determined by dividing the desired mg amount by the final mg/mL concentration.
Melanotan 2 is studied for its potential influence on:
Melanocortin Receptor Activity
MC1R pathway activation
Pigment-production signaling
Melanocyte stimulation modeling
Pigmentation Dynamics
Melanin synthesis pathways
UV-response research frameworks
Skin-tone variation studies
Neuroendocrine Signaling
Hypothalamic melanocortin activity
Appetite and behavioral pathway observation
CNS receptor interaction analysis
Its receptor-mediated mechanism differentiates it from structural or metabolic peptides.
Within structured research environments, investigators may observe:
Dose-dependent variables
Flushing
Nausea
Appetite suppression trends
Pigmentation-related observations
Gradual skin-darkening response
Freckle or mole darkening within models
Less frequent observations
Headache
Injection-site irritation
Transient fatigue
Monitoring intensity may increase during initial receptor activation phases.
Administration Frequency: Varies by study design (often episodic or titrated protocols)
Common Study Duration: 4–8 weeks
Titration Strategy: Gradual incremental adjustments to evaluate receptor response
Researchers often exercise caution when combining Melanotan 2 with other melanocortin-modulating compounds to avoid additive pathway effects.
Store lyophilized vial in a cool, dry environment.
Refrigerate after reconstitution.
Maintain sterile laboratory handling procedures at all times.
